title: Netupitant and palonosetron (NEPA): a winning team in the race for the optimal treatment of chemotherapy-induced nausea and vomiting?
authors.affiliation: Division of Biomedical Sciences, St George's University of London, Cranmer Terrace, London, UK. Electronic address: pandrews@sgul.ac.uk.
authors.forename: P L R
authors.initials: PLR
authors.lastname: Andrews
mesh_terms: D000932:Antiemetics / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage*; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D000077924:Palonosetron; D011725:Pyridines / Q000008:administration & dosage*; D011812:Quinuclidines / Q000008:administration & dosage*; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*; D010879:Piperazines; D044482:Benzeneacetamides
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents; D007546:Isoquinolines; D000077924:Palonosetron; D011725:Pyridines; D011812:Quinuclidines; C508854:netupitant; D010879:Piperazines; D044482:Benzeneacetamides